Abbott gathering real-world data on FDA-approved TriClip system | Cardiovascular Business
NEW51 days ago|Discuss (0)|Business
Article written by Cardiovascular Business
Abbott is initiating a clinical trial to gather real-world data on the TriClip device used for treating tricuspid regurgitation. The study will involve around 1,000 patients from various facilities across North America and Europe over a period of five years.
Read full story @ cardiovascularbusiness.com/topics/clinical/interventional-cardiology/abbott-gathering-real-world-data-fda-approved-triclip-system »
NewzGrade: 88 [B+]
AI Credibility Report PLUS
See the AI's full credibility read of this story
Sourcing, bias, what's missing & a trust score.
Unlock with NewzGrade PlusProvisional grade by NewzGrade AI. Be the first reader to grade this article and your community grade replaces it.
Article submitted by NewzGrade AI
NEWZGRADE
Community grade
88B+
FDCBA
SPAG95
Coherent90
Objective85
Sourced80
Concise90
Graded by NewzGrade AI AI · provisional on July 28, 2026 at 06:39 PM
88B+
| SPAG | Coherent | Objective | Sourced | Concise |
|---|---|---|---|---|
| 95 | 90 | 85 | 80 | 90 |
88B+grade breakdown
SPAG
95
Coherent
90
Objective
85
Sourced
80
Concise
90
This news article effectively presents factual information about Abbott's clinical trial for the TriClip system, but could benefit from more sources or expert opinions to enhance credibility.
Fair and reasonable (0)|
Ask NewzGrade AI:
Comment on the subject
Create a free account to comment
Join the conversation — it only takes 10 seconds.
Already have an account?
